Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ALZN stock hub

Alzamend Neuro, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALZNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALZN

In the news

Latest news · ALZN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-250

P25 -105.6P50 -46.5P75 -3.1

ROIC-156.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALZN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001677077
Company name	Alzamend Neuro, Inc.
Country	United States
Country code	US
Cusip	02262M605
Employees	6
Employees Change	-1%
Employees Change Percent	-14.29
Enterprise value	$1.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-06-15
Isin	US02262M6057
Last refreshed	2026-05-10
Market cap	$4.1M
Market cap category	Nano-Cap
Price	$1.07
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ALZN
Website	https://www.alzamend.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-185.33%
FCF yield	-151.54%
P/B ratio	1.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.5M
Net Income Growth Years	2%
Profit Per Employee	$-1.3M
ROA	-107
Roa5y	-121.5
ROCE	-322
ROE	-250
Roe5y	-1,152.8
ROIC	-156.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-80.07%
Cagr3y	-88.44%
EPS Growth Quarters	10
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4M
Cash	$2.7M
Current Assets	$3.7M
Current Liabilities	$1.9M
Equity	$2.2M
Interest Coverage	-1,008.2
Liabilities	$1.9M
Long Term Assets	$342,551
Long Term Liabilities	$0
Net Cash	$2.7M
Net Cash By Market Cap	$66.64
Net Cash Growth	-19.21%
Net Debt Equity	$-1.24
Tangible Book Value	$2.2M
Tangible Book Value Per Share	$0.57
WACC	4.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.99
Net Working Capital	$-871,185
Quick ratio	1.46
Working Capital	$1.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-765.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-80.05%
200-day SMA	2.06
3Y total return	-99.85%
50-day SMA	1.41
50-day SMA vs 200-day SMA	50under200
All Time High	45,292.5
All Time High Change	-100%
All Time High Date	2021-06-15
All Time Low	0.84
All Time Low Change	27.38%
All Time Low Date	2026-04-13
ATR	0.09
Beta	0.11
Beta1y	1.73
Beta2y	0.91
Ch YTD	-41.21
High	1.08
High52	8.22
High52 Date	2025-05-29
High52ch	-86.98%
Low	1.01
Low52	0.84
Low52 Date	2026-04-13
Low52ch	27.38%
Ma50ch	-23.9%
Premarket Change Percent	0
Premarket Price	$1.06
Price vs 200-day SMA	-47.96%
RSI	42.14
RSI Monthly	10.09
RSI Weekly	31.69
Sharpe ratio	-1x
Sortino ratio	-1.46
Total Return	-765.27%
Tr YTD	-41.21
Tr1m	15.48%
Tr1w	-4.46%
Tr3m	-45.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.45
Operating Income	$-7M
Price target	$28
Price Target Change	$2,517

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,792,882%
Float Percent	99.69%
Shares Insiders	0.02%
Shares Institutions	9.52%
Shares Out	3,804,741
Shares Qo Q	12.53%
Shares Yo Y	765.27%
Short Float	6.55%
Short Ratio	0.93
Short Shares	6.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.3M
Average Volume	65,933.05x
Bv Per Share	0.57
CAPEX	$-210,000
Ch1m	15.48
Ch1w	-4.46
Ch1y	-80.05
Ch3m	-45.96
Ch3y	-99.85
Ch6m	-55.04
Change	0.94%
Change From Open	4.9
Close	1.06
Days Gap	-3.77
Depreciation Amortization	95,740
Dollar Volume	47,137.8
Earnings Date	2026-03-11
Earnings Time	amc
EBIT	$-7M
EBITDA	$-6.9M
EPS	$-2.99
F Score	1
FCF	$-6.2M
FCF EV Yield	-454.31x
FCF Per Share	$-1.62
Financing CF	5,524,228
Fiscal Year End	April
Founded	2,016
Investing CF	-210,000
Ipr	-78.6
Iprfo	-100
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2026-01-31
Last Split Date	2025-05-12
Last Split Type	Reverse
Last10k Filing Date	2025-07-22
Ma150	1.93
Ma150ch	-44.67%
Ma20	1.08
Ma20ch	-0.47%
Net CF	-644,996
Next Earnings Date	2026-07-21
Open	1.02
Optionable	No
Position In Range	85.71
Post Close	1.07
Postmarket Change Percent	0.93
Postmarket Price	$1.08
Ppne	342,551
Pre Close	1.06
Price Date	2026-05-08
Ptbv Ratio	1.86
Relative Volume	0.67x
Share Based Comp	164,993
Tr6m	-55.04%
Us State	Georgia
Volume	44,054

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALZN pay a dividend?

Capital-return profile for this ticker.

Performance

ALZN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALZN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.5%

Float: +99.7% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALZN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-48.0%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

-1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALZN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALZN stock rating?

Alzamend Neuro, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALZN analysis?

The full report lives at /stocks/ALZN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALZN?

The latest report frames ALZN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALZN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.